FDA Inspection
South Bend Medical Foundation, Inc.South Bend Medical Foundation, Inc. – FDA Inspection, Aug 9, 2019
Record Details
This FDA Inspection record concerns South Bend Medical Foundation, Inc., with an inspection on August 9, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a947c8e0-f40a-4d8c-88c5-5b8107e48004
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099142
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.200(a)Cleaned, sanitized per established schedules
- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of South Bend Medical Foundation, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2025 | VAI | Detroit District Office | Blood and Blood Products |
| September 1, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 19, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 1, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 10, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for South Bend Medical Foundation, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.